Voie d'immunisation et séquence d'administration de l ... - TEL

tel-00827710, version 1 - 29 May 2013
Marshall, H.D., Urban, S.L., and Welsh, R.M. (2011). Virus-induced transient immune
suppression and the inhibition of T cell proliferation by type I interferon. J Virol 85, 5929-
5939.
Marzo, A.L., Klonowski, K.D., Le Bon, A., Borrow, P., Tough, D.F., and Lefrancois, L.
(2005). Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat
Immunol 6, 793-799.
Mattei, F., Bracci, L., Tough, D.F., Belardelli, F., and Schiavoni, G. (2009). Type I IFN
regulate DC turnover in vivo. Eur J Immunol 39, 1807-1818.
Mattner, J., Schindler, H., Diefenbach, A., Rollinghoff, M., Gresser, I., and Bogdan, C.
(2000). Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages
infected with Leishmania major. Eur J Immunol 30, 2257-2267.
Matzinger, P. (1994). Tolerance, danger, and the extended family. Annu Rev Immunol 12,
991-1045.
McBride, S., Hoebe, K., Georgel, P., and Janssen, E. (2006). Cell-associated double-stranded
RNA enhances antitumor activity through the production of type I IFN. J Immunol 177, 6122-
6128.
Melief, C.J., and van der Burg, S.H. (2008). Immunotherapy of established (pre)malignant
disease by synthetic long peptide vaccines. Nat Rev Cancer 8, 351-360.
Mercado, R., Vijh, S., Allen, S.E., Kerksiek, K., Pilip, I.M., and Pamer, E.G. (2000). Early
programming of T cell populations responding to bacterial infection. J Immunol 165, 6833-
6839.
Mescher, M.F., Curtsinger, J.M., Agarwal, P., Casey, K.A., Gerner, M., Hammerbeck, C.D.,
Popescu, F., and Xiao, Z. (2006). Signals required for programming effector and memory
development by CD8+ T cells. Immunol Rev 211, 81-92.
Mihm, S., Frese, M., Meier, V., Wietzke-Braun, P., Scharf, J.G., Bartenschlager, R., and
Ramadori, G. (2004). Interferon type I gene expression in chronic hepatitis C. Lab Invest 84,
1148-1159.
Miyagi, T., Gil, M.P., Wang, X., Louten, J., Chu, W.M., and Biron, C.A. (2007). High basal
STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer
cells. J Exp Med 204, 2383-2396.
Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., and Nagata, S. (2007).
Identification of Tim4 as a phosphatidylserine receptor. Nature 450, 435-439.
Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P., and Tough,
D.F. (2002). Type I interferons produced by dendritic cells promote their phenotypic and
functional activation. Blood 99, 3263-3271.
Moon, J.J., Chu, H.H., Pepper, M., McSorley, S.J., Jameson, S.C., Kedl, R.M., and Jenkins,
M.K. (2007). Naive CD4(+) T cell frequency varies for different epitopes and predicts
repertoire diversity and response magnitude. Immunity 27, 203-213.
Mortier, E., Advincula, R., Kim, L., Chmura, S., Barrera, J., Reizis, B., Malynn, B.A., and
Ma, A. (2009). Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports
homeostasis of distinct CD8+ T cell subsets. Immunity 31, 811-822.
Nagai, T., Devergne, O., Mueller, T.F., Perkins, D.L., van Seventer, J.M., and van Seventer,
G.A. (2003). Timing of IFN-beta exposure during human dendritic cell maturation and naive
Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-betamediated
regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J
Immunol 171, 5233-5243.
Page 247 of 256